Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
DXRthis companyDaxor Corporation	$8.42	8.02×	1.6×	146.07×	8.02×	-100.3%	37.5%	1824.7%	1821.5%	20.0%	20.0%	-0.8%	0×	0.01×	575.44×	0×	0.0%	3	1,336.57	3	B+
ACETAdicet Bio, Inc.	$3.15	-0.5×	0.36×	0×	-0.31×	-8.6%	0.0%	0.0%	0.0%	-73.4%	-70.2%	-167.1%	0.09×	0.22×	-3,392.06×	7.47×	0.0%	1	-6.93	3	B-
BEATHeartBeam, Inc.	$0.41	-3.87×	31.08×	0×	-3.65×	-74.8%	0.0%	0.0%	0.0%	-807.3%	-812.1%	-18.0%	0×	0.21×	0×	1.45×	0.0%	2	-11.41	1	C-
CRVOCervoMed Inc.	$1.42	-2.65×	3.92×	0×	-2.34×	-51.0%	0.0%	0.0%	0.0%	-148.0%	-151.0%	-32.8%	0×	0.31×	0×	4.84×	0.0%	2	-3.92	2	C
GANXGain Therapeutics, Inc.	$1.08	-5.28×	5.72×	0×	-4.48×	-46.1%	0.0%	0.0%	0.0%	-108.6%	-95.0%	-17.4%	0.04×	1.05×	0×	6.63×	0.0%	3	-6.34	2	C
GEGGreat Elm Group, Inc.	$2.11	-1.86×	1.62×	2.38×	-6.05×	151.2%	-22.9%	-50.4%	-127.6%	-86.9%	-13.0%	18.0%	1.58×	-0.86×	-3.41×	12.89×	0.0%	4	-39.54	1	C-
Peer median	—	-2.65×	3.92×	0×	-3.65×	-46.1%	0.0%	0.0%	0.0%	-108.6%	-95.0%	-18.0%	0.04×	0.22×	0×	6.63×	0.0%	2	-6.93	2	—